These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6765970)

  • 1. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.
    Zighelboim J
    Cancer Res; 1979 Sep; 39(9):3357-62. PubMed ID: 314332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow transplantation in aplastic anemia and leukemia.
    Weiden PL; Thomas ED; Storb R; Fefer A; Neiman PE; Clift RA; Buckner CD; Lerner KG
    Compr Ther; 1976 Apr; 2(4):57-62. PubMed ID: 4261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow transplantation for leukemia and aplastic anemia.
    Thomas ED; Buckner CD; Cheever MA; Clift RA; Einstein AB; Fefer A; Neiman PE; Sanders J; Storb R; Weiden PL
    Transplant Proc; 1976 Dec; 8(4):603-5. PubMed ID: 11590
    [No Abstract]   [Full Text] [Related]  

  • 8. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for acute leukaemia and severe marrow aplasia: an analysis of five patients.
    Beard ME; Heaton DC; Hamer JW; Watson J; Fox HW; Crosier PS; Abbott GD
    N Z Med J; 1981 Oct; 94(693):249-52. PubMed ID: 7033845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.
    Keever CA; Klein J; Leong N; Copelan EA; Avalos BR; Kapoor N; Cunningham I; Tutschka PJ
    Bone Marrow Transplant; 1993 Sep; 12(3):289-95. PubMed ID: 8241989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow transplantation in Seattle. Improved treatment in aplastic anemia and acute leukemia].
    Ringdén O
    Lakartidningen; 1979 Dec; 76(50):4588-92. PubMed ID: 43441
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
    Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
    Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus in patients with allogeneic bone marrow transplants.
    Beschorner WE; Hutchins GM; Elfenbein GJ; Santos GW
    Am J Pathol; 1978 Jul; 92(1):173-86. PubMed ID: 356622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation for aplastic anemia or acute leukemia.
    Thomas ED
    Scand J Urol Nephrol Suppl; 1977; (42):6-11. PubMed ID: 356224
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response to transplantation antigens in human marrow graft recipients.
    Weiden PL; Storb R; Mickelson EM; Warren RP; Thomas ED
    Transplant Proc; 1978 Jun; 10(2):409-13. PubMed ID: 27890
    [No Abstract]   [Full Text] [Related]  

  • 18. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.